The University of Chicago Header Logo

Connection

Arthur Herbst to Diethylstilbestrol

Back to Details
This is a "connection" page, showing publications Arthur Herbst has written about Diethylstilbestrol.
Arthur Herbst
Connection Strength
7.212
Diethylstilbestrol
  1. Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix. N Engl J Med. 2018 05 03; 378(18):1746-1748.
    View in: PubMed
    Score: 0.626
  2. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017 09; 146(3):566-571.
    View in: PubMed
    Score: 0.592
  3. Diethylstilbestrol (DES) Pregnancy Treatment: A Promising Widely Used Therapy with Unintended Adverse Consequences. AMA J Ethics. 2015 Sep 01; 17(9):865-70.
    View in: PubMed
    Score: 0.521
  4. Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma. Obstet Gynecol. 2000 Jun; 95(6 Pt 1):814-20.
    View in: PubMed
    Score: 0.181
  5. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecol Oncol. 2000 Feb; 76(2):147-56.
    View in: PubMed
    Score: 0.177
  6. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol. 1999 Dec; 181(6):1574-5.
    View in: PubMed
    Score: 0.175
  7. Diethylstilbestrol and adenocarcinoma of the vagina. Am J Obstet Gynecol. 1999 Dec; 181(6):1576-8; discussion 1579.
    View in: PubMed
    Score: 0.175
  8. Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2019 03; 84:32-38.
    View in: PubMed
    Score: 0.164
  9. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. Am J Obstet Gynecol. 2016 09; 215(3):322.e1-8.
    View in: PubMed
    Score: 0.135
  10. Self-reported allergy, infection, and autoimmune diseases among men and women exposed in utero to diethylstilbestrol. J Clin Epidemiol. 1996 Feb; 49(2):263-6.
    View in: PubMed
    Score: 0.134
  11. Age at menarche among diethylstilbestrol granddaughters. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):835-6.
    View in: PubMed
    Score: 0.130
  12. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med. 1995 May 25; 332(21):1411-6.
    View in: PubMed
    Score: 0.128
  13. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2015 Apr; 24(4):308-15.
    View in: PubMed
    Score: 0.126
  14. Onset of menopause in women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol. 1995 Jan; 172(1 Pt 1):92-5.
    View in: PubMed
    Score: 0.124
  15. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol. 1994 Nov; 55(2):238-44.
    View in: PubMed
    Score: 0.123
  16. DES exposure: an update. Contemp Pediatr. 1994 Nov; 11(11):59-62, 64, 66 passim.
    View in: PubMed
    Score: 0.123
  17. Effects on the menstrual cycle of in utero exposure to diethylstilbestrol. Am J Obstet Gynecol. 1994 Mar; 170(3):709-15.
    View in: PubMed
    Score: 0.117
  18. Medical conditions among adult offspring prenatally exposed to diethylstilbestrol. Epidemiology. 2013 May; 24(3):430-8.
    View in: PubMed
    Score: 0.111
  19. Prenatal diethylstilbestrol exposure and performance on college entrance examinations. Horm Behav. 1992 Sep; 26(3):433-9.
    View in: PubMed
    Score: 0.106
  20. Mammography screening behaviors of women exposed prenatally to diethylstilbestrol. J Womens Health (Larchmt). 2012 Feb; 21(2):209-14.
    View in: PubMed
    Score: 0.100
  21. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011 Oct 06; 365(14):1304-14.
    View in: PubMed
    Score: 0.099
  22. Clear cell adenocarcinoma of the lower genital tract. Correlation of mother's recall of diethylstilbestrol history with obstetrical records. Cancer. 1990 Nov 15; 66(10):2215-20.
    View in: PubMed
    Score: 0.093
  23. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol. 1990; 6(6):343-6.
    View in: PubMed
    Score: 0.088
  24. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health. 2009 Aug 18; 8:37.
    View in: PubMed
    Score: 0.086
  25. Breast cancer screening in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2009 Apr; 18(4):547-52.
    View in: PubMed
    Score: 0.083
  26. Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. J Low Genit Tract Dis. 2008 Apr; 12(2):111-7.
    View in: PubMed
    Score: 0.078
  27. Infertility among daughters either exposed or not exposed to diethylstilbestrol. Am J Obstet Gynecol. 1988 Mar; 158(3 Pt 1):493-8.
    View in: PubMed
    Score: 0.077
  28. Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology. 2008 Mar; 19(2):251-7.
    View in: PubMed
    Score: 0.077
  29. Secondary sex ratio among women exposed to diethylstilbestrol in utero. Environ Health Perspect. 2007 Sep; 115(9):1314-9.
    View in: PubMed
    Score: 0.075
  30. Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer. 2007 Jul 15; 121(2):356-60.
    View in: PubMed
    Score: 0.074
  31. Preeclampsia risk in women exposed in utero to diethylstilbestrol. Obstet Gynecol. 2007 Jul; 110(1):113-20.
    View in: PubMed
    Score: 0.074
  32. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med. 1987 Feb 26; 316(9):514-6.
    View in: PubMed
    Score: 0.072
  33. The effects in the human of diethylstilbestrol (DES) use during pregnancy. Princess Takamatsu Symp. 1987; 18:67-75.
    View in: PubMed
    Score: 0.071
  34. Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol. 2006 Oct 01; 164(7):682-8.
    View in: PubMed
    Score: 0.069
  35. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1509-14.
    View in: PubMed
    Score: 0.069
  36. Mortality in women given diethylstilbestrol during pregnancy. Br J Cancer. 2006 Jul 03; 95(1):107-11.
    View in: PubMed
    Score: 0.069
  37. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol. 2006 Aug; 35(4):862-8.
    View in: PubMed
    Score: 0.068
  38. Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol. 1986 Apr; 154(4):814-22.
    View in: PubMed
    Score: 0.068
  39. Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology. 2005 Jul; 16(4):583-6.
    View in: PubMed
    Score: 0.064
  40. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol. 2005 Jan; 105(1):167-73.
    View in: PubMed
    Score: 0.062
  41. Diethylstilbestrol exposure--1984. N Engl J Med. 1984 Nov 29; 311(22):1433-5.
    View in: PubMed
    Score: 0.062
  42. Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control. 2002 Oct; 13(8):753-8.
    View in: PubMed
    Score: 0.053
  43. DES-related female genital changes. Semin Oncol. 1982 Sep; 9(3):341-8.
    View in: PubMed
    Score: 0.053
  44. Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am J Obstet Gynecol. 1981 Dec 15; 141(8):1019-28.
    View in: PubMed
    Score: 0.050
  45. Diethylstilbestrol and other sex hormones during pregnancy. Obstet Gynecol. 1981 Nov; 58(5 Suppl):35S-40S.
    View in: PubMed
    Score: 0.050
  46. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control. 2001 Nov; 12(9):837-45.
    View in: PubMed
    Score: 0.050
  47. Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol. 2001 Aug 15; 154(4):316-21.
    View in: PubMed
    Score: 0.049
  48. Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer. 1981 Jul 15; 48(2 Suppl):484-8.
    View in: PubMed
    Score: 0.049
  49. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst. 2001 Apr 04; 93(7):545-51.
    View in: PubMed
    Score: 0.048
  50. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer. 2001 Jan 05; 84(1):126-33.
    View in: PubMed
    Score: 0.047
  51. The current status of the DES-exposed population. Obstet Gynecol Annu. 1981; 10:267-78.
    View in: PubMed
    Score: 0.047
  52. DES update. Interview by Arthur I. Holleb. CA Cancer J Clin. 1980 Nov-Dec; 30(6):326-32.
    View in: PubMed
    Score: 0.047
  53. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol. 2000 Oct; 96(4):483-9.
    View in: PubMed
    Score: 0.046
  54. A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters. J Reprod Med. 1980 Feb; 24(2):62-9.
    View in: PubMed
    Score: 0.044
  55. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979 Dec 01; 135(7):876-86.
    View in: PubMed
    Score: 0.044
  56. DES-associated clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol Surv. 1979 Nov; 34(11):844.
    View in: PubMed
    Score: 0.043
  57. A correlative nuclear DNA and histologic study of genital squamous lesions in DES exposed progeny. Obstet Gynecol Surv. 1979 Nov; 34(11):849-50.
    View in: PubMed
    Score: 0.043
  58. Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr. 1979 May; (51):25-35.
    View in: PubMed
    Score: 0.042
  59. Complications of prenatal therapy with diethylstilbestrol. Pediatrics. 1978 Dec; 62(6 Pt 2):1151-9.
    View in: PubMed
    Score: 0.041
  60. Comparison of histologic and colposcopic findings in DES-exposed females. Obstet Gynecol. 1978 Oct; 52(4):457-61.
    View in: PubMed
    Score: 0.040
  61. A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med. 1978 Apr 06; 298(14):763-7.
    View in: PubMed
    Score: 0.039
  62. Evaluation and management of diethylstilbestrol-exposed offspring. Surg Clin North Am. 1978 Feb; 58(1):87-96.
    View in: PubMed
    Score: 0.038
  63. Pathology of prenatal diethylstilbestrol exposure. Pathol Annu. 1978; 13 Pt 1:201-16.
    View in: PubMed
    Score: 0.038
  64. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1977 May 01; 128(1):43-50.
    View in: PubMed
    Score: 0.037
  65. Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977 Apr; 39(4 Suppl):1892-5.
    View in: PubMed
    Score: 0.036
  66. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. Arch Pathol Lab Med. 1977 Jan; 101(1):1-5.
    View in: PubMed
    Score: 0.036
  67. Cytology of 575 young women with prenatal exposure to diethylstilbestrol. Obstet Gynecol. 1976 Nov; 48(5):511-5.
    View in: PubMed
    Score: 0.035
  68. Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J Toxicol Environ Health Suppl. 1976; 1:13-20.
    View in: PubMed
    Score: 0.033
  69. Vaginal adenosis and other diethylstilbestrol-related abnormalities. Clin Obstet Gynecol. 1975 Sep; 18(3):185-94.
    View in: PubMed
    Score: 0.033
  70. Editorial: Problems in the examination of the DES-exposed female. Obstet Gynecol. 1975 Sep; 46(3):353-5.
    View in: PubMed
    Score: 0.033
  71. Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med. 1975 Feb 13; 292(7):334-9.
    View in: PubMed
    Score: 0.031
  72. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994 Sep; 84(3):404-8.
    View in: PubMed
    Score: 0.030
  73. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Ann Clin Lab Sci. 1974 Jul-Aug; 4(4):222-33.
    View in: PubMed
    Score: 0.030
  74. The effects of local progesterone on stilbestrol-associated vaginal adenosis. Am J Obstet Gynecol. 1974 Mar 01; 118(5):607-15.
    View in: PubMed
    Score: 0.029
  75. Stilbestrol and vaginal cancer in young women. CA Cancer J Clin. 1972 Sep-Oct; 22(5):292-5.
    View in: PubMed
    Score: 0.026
  76. Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol. 1972 Sep; 40(3):287-98.
    View in: PubMed
    Score: 0.026
  77. Stilbestrol-adenosis-carcinoma syndrome: geographic distribution. N Engl J Med. 1971 Sep 16; 285(12):691.
    View in: PubMed
    Score: 0.025
  78. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 04 22; 284(15):878-81.
    View in: PubMed
    Score: 0.024
  79. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer. 1984 Sep 01; 54(5):869-75.
    View in: PubMed
    Score: 0.015
  80. An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol. 1979 Apr; 7(2):111-22.
    View in: PubMed
    Score: 0.010
  81. Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol. 1978 Apr; 51(4):453-8.
    View in: PubMed
    Score: 0.010
  82. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Cancer Res. 1977 Apr; 37(4):1249-51.
    View in: PubMed
    Score: 0.009
  83. Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). J Reprod Med. 1975 Jul; 15(1):13-18.
    View in: PubMed
    Score: 0.008
  84. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. J Reprod Med. 1975 Jul; 15(1):5-11.
    View in: PubMed
    Score: 0.008
  85. Delayed disease as a consequence of fetal exposure to radiation, infection, and exogenous hormones. Clin Perinatol. 1974 Sep; 1(2):483-90.
    View in: PubMed
    Score: 0.008
  86. Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 01; 119(5):713-24.
    View in: PubMed
    Score: 0.008
  87. Exogenous hormones in pregnancy. Clin Obstet Gynecol. 1973 Dec; 16(4):37-50.
    View in: PubMed
    Score: 0.007
  88. Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21; 287(25):1259-64.
    View in: PubMed
    Score: 0.007
  89. Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. Obstet Gynecol. 1982 Nov; 60(5):546-51.
    View in: PubMed
    Score: 0.003
  90. Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer. 1974 Sep; 34(3):606-14.
    View in: PubMed
    Score: 0.002
  91. Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Acta Cytol. 1974 Jul-Aug; 18(4):279-90.
    View in: PubMed
    Score: 0.002
  92. Registry of clear-cell carcinoma of genital tract in young women. N Engl J Med. 1971 Aug 12; 285(7):407.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.